You are here

PAH

United Therapeutics tosses out esuberaprost after trial flop

Fierce Biotech

Mon, 04/8/19 - 09:59 am

United Therapeutics

clinical trials

Targeting underlying cause of PAH, Cambridge spinout Morphogen-IX raises about $23M in Series B

Endpoints

Wed, 12/19/18 - 12:26 am

Actelion inks $360M deal to resolve DOJ kickbacks probe

Fierce Pharma

Thu, 12/6/18 - 06:54 pm

Arena’s Comeback Continues with $800M Deal for Blood Disease Drug

Xconomy

Thu, 11/15/18 - 11:41 pm

Arena Pharmaceuticals

United Therapeutics

Struggling MannKind sees shares rocket up on $105M-plus alliance with United on inhaled treprostinil

Endpoints

Tue, 09/4/18 - 09:43 am

United Therapeutics

Mylan Launches First Adcirca Generic, Stock Moves Up

Market Realist

Mon, 08/13/18 - 05:56 pm

United Therapeutics

Medtronic wins FDA nod to deliver PAH therapy with implantable pump

Drug Delivery Business News

Tue, 07/31/18 - 09:57 am

United Therapeutics

GSK-backed Liquidia takes a seat at the IPO table, looking for a $57.5M stake to take on United Therapeutics

Endpoints

Mon, 07/2/18 - 09:35 am

United Therapeutics

Pluristem Reports Positive Top-Line PhII Results From Its Placenta Derived Cell Therapy In Peripheral Artery Disease

CP Wire

Tue, 06/12/18 - 11:24 am

intermittent claudication

MannKind (MNKD) Completes Phase 1 Trial of Treprostinil Technosphere for PAH Advancing Development to Next Phase

Street Insider

Fri, 06/8/18 - 11:00 am

Here's What Lifted Arena Pharmaceuticals, Inc. Stock in September

Motley Fool

Tue, 10/10/17 - 09:36 am

Arena Pharmaceuticals

pulmonary arterial hypertension

Arena Pharma Skyrockets on Heart Disease Data, Stock Could Still Double -Firm Says

TheStreet.com

Mon, 07/17/17 - 07:05 pm

Arena Pharmaceuticals

pulmonary arterial hypertension

Arena takes a big step down the comeback trail with PhII success, shares rocket up

Endpoints

Tue, 07/11/17 - 11:18 am

Arena Pharmaceuticals

clinical trials

pulmonary arterial hypertension

How Is United Therapeutics’ Remodulin Positioned in 2017?

Market Realist

Mon, 07/3/17 - 09:46 am

United Therapeutics

pulmonary arterial hypertension

EMA panel recommends that use of Actelion's Uptravi may continue

Yahoo/Reuters

Sat, 02/11/17 - 12:32 pm

pulmonary arterial hypertension

Actelion drug fails trial, denting revenue potential

Yahoo/Reuters

Mon, 01/23/17 - 10:19 am

clinical trials

pulmonary arterial hypertension

J&J's $26 Billion Swiss Drugs Experiment

Bloomberg

Mon, 12/5/16 - 10:07 am

United Therapeutics sees stepped-up competition and says it's 'a good thing'

Bizjournals.com

Tue, 03/1/16 - 10:59 pm

United Therapeutics

pulmonary arterial hypertension

Could an old Roche arthritis med become a pioneering PAH treatment?

BioPharma Dive

Thu, 01/7/16 - 09:32 am

pulmonary arterial hypertension

Actelion sees Uptravi price of $160,000-170,000/patient

Yahoo/Reuters

Tue, 01/5/16 - 02:47 pm

pulmonary arterial hypertension

Pages